Svetlana I. Nihtyanova

Prediction of Pulmonary Complications and Long‐Term Survival in Systemic Sclerosis

Svetlana I. Nihtyanova, Benjamin Schreiber, Voon H Ong et al. · Arthritis & Rheumatology · 2014 · 457 citations

Medicine, Clinical Sciences, Internal Medicine +15

Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis

Korsa Khan, Shiwen Xu, Svetlana I. Nihtyanova et al. · Annals of the Rheumatic Diseases · 2012 · 218 citations

Medicine, Immunology, Pathology +17

Using Autoantibodies and Cutaneous Subset to Develop Outcome‐Based Disease Classification in Systemic Sclerosis

Svetlana I. Nihtyanova, Jennifer Harvey, Anna Leslie et al. · Arthritis & Rheumatology · 2019 · 214 citations · Full text

Life Sciences, Clinical Sciences, Immunology +16

Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: Application of a latent linear trajectory model

L Shand, Mark Lunt, Svetlana I. Nihtyanova et al. · Arthritis & Rheumatism · 2007 · 209 citations

Medicine, Clinical Sciences, Dermatology +15

Mycophenolate mofetil in diffuse cutaneous systemic sclerosis--a retrospective analysis

Svetlana I. Nihtyanova, Geraldine Brough, C. M. Black et al. · Lara D. Veeken · 2006 · 203 citations

Medicine, Clinical Sciences, Pharmacotherapy +13